March 1, 2021

Explained: Why a French advisory panel recommended delaying the second shot of the Govt vaccine

France’s top health advisory body Hot Autoride de Sante (HAS) on Saturday (January 23) recommended doubling the deadline for providing the first and second shots of the vaccine against the corona virus novel. .

France has begun its vaccination with the elderly and health workers, and under the current protocol, there is a three-week gap between காட்ச two shows for those in retirement homes and four weeks for health workers.

Authorities now want to extend the break to six weeks.

How can increasing the spacing between levels help?

The priority of the French authorities seems to be to vaccinate as many people as possible.

Increasing the gap between the first and second shots will allow at least 7 lakh people to be vaccinated in the first month of the vaccination program, HAS reported, Reuters reported.

France uses Pfizer-Bioentech and Modern vaccines.

According to a Reuters report, the growing number of infections and the alarming arrival of new variants have called for the vaccination campaign to be accelerated.

So is there a shortage of vaccines in France?

A shortage has been reported in many countries. HAS’s advice – it’s an independent body whose recommendations are not tied to the government – suggests a policy debate in France on how to use non – abundant materials.

The New York Times reported similar shortages in the United States, citing examples from states including Texas, South Carolina and California.

“Suddenly the supply of vaccines stopped,” said Dr. Esmail Borsa, chief executive of Houston – based Houston Health System, which runs hospitals and clinics in Harris County, Texas, citing the New York Times.

“It’s confusing and frustrating because a high percentage of vaccines have been distributed, but I’m asking that they not be administered,” Dr. Porsche was quoted as saying.

The New York Times report provided examples of vaccine shortages in various parts of the United States.

In Beafort, South Carolina, a hospital had to cancel 6,000 appointments after receiving only 450 doses of the vaccine, the report said. In Maui, Hawaii, a hospital had to cancel 5,000 first-dose appointments and postpone 15,000 requests for appointments. The San Francisco Department of Public Health fears it will run out of vaccines after its allocation falls sharply, and in Eri County, New York, “thousands” of vaccination appointments have been canceled in recent days, the NYT report said.

But can’t just one shot of the vaccine do the trick?

No. All three major vaccines, developed by Pfizer-Bioendech, Moderna and Oxford-Astrogeneneka, require two doses to extend full protection.

As part of its advice, the French HAS underscored the need for everyone to get a second shot, a Reuters report said.

The World Health Organization said this month that two doses of the Pfizer-Bioentech vaccine should be given within 21-28 days.

Can the gap between the sizes be widened?

Reuters reports that many countries are considering ways to prolong shortages by delaying dosing intervals or reducing dose levels.

Pfizer-Biotech has stated that there is no evidence that the vaccine will continue to protect against the corona virus novel if the second dose is given more than 21 days after the first dose.

In the UK, regulators have said they can administer footage at 12-week intervals – however, the Reuters British medical team has written to the UK chief medical officer to reduce the interval between doses of the Pfizer-Bioendech vaccine to six weeks. The report added.

N Join Now: Express explained telegraph channel

Is there enough vaccine for India?

For now, yes. In fact, India’s current concern is a measure of vaccine reluctance, which has manifested itself in a particular reluctance to take shots.

The Serum Institute of India, the world’s largest vaccine maker, which manufactures the Oxford-Astrogeneca vaccine under license in India and many other countries, has repeatedly insisted that there is no shortage of Govshield’s sizes.

Besides, Bharat Biotech’s Kovacsin supply will soon accelerate. The government has promised that many vaccines will be available to the Indian people by the summer.